Shoppers Drug Mart may have yet to receive its medical cannabis license from Health Canada, but it is moving full steam ahead to make sure it has secured multiple Canadian cannabis suppliers to provide its customers with products.
Tag Archives: Aphria
Tetra Bio-Pharma Receives Health Canada Phase 3 Clinical Trial Approval For Smokable Dried Cannabis Prescription Drug
OTTAWA, Ontario, Feb. 5, 2018 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD) Health Canada to its Clinical trial application (CTA) for the Company’s PPP001 prescription smokable dried cannabis product.
Liberty Health Sciences Announces New Strategic Investors With Proven Investment Experience In Cannabis Industry
TORONTO, Ontario, Feb. 5, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) is pleased to announce today that a group of buyers led by members of the Serruya family (the “Group”) has entered into a purchase and sale agreement with Aphria Inc.
Aphria Begins to Divest of its Equity Investment in Passive US Assets
LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.
Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty
LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).
Shoppers Drug Mart Marijuana Closer to Reality With Second Supplier Named
Shoppers Drug Mart marijuana is one step closer to reality after a public Canadian marijuana company announced that it has signed on to be the Canadian pharmacy chain’s second medical marijuana supplier.
Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart
Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.
Canada Weed Stocks Come Off High as Challenges Loom Before Legalization
Canada’s weed stocks, which have surrendered some of the potent gains that pushed them to record highs this month, face a bumpy ride in 2018 that could purge smaller players, as the country moves to allow recreational use of cannabis in July.
Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria
OTTAWA, Ontario Nov. 16, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps(TM), unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).
Tetra Bio-Pharma Hires Medical Science Liaison to Promote Rx Princeps(TM) and Presents its New Corporate Image
OTTAWA, Oct. 19, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the hiring of Dr. Vincent Jourdain, Ph. D. as medical science liaison (MSL).
Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR
OTTAWA, Ontario, Oct. 18, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it will start promoting a co-developed medical cannabis blend product under Access to Cannabis for Medical Purposes Regulations (ACMPR).
2 Metrics All Cannabis Stock Investors Need to Know
Marijuana stock investors are going to have to keep their eyes on the following two critical data points for each and every marijuana stock they’re considering buying, or that they already own.
Survey: Canadian Cannabis Salaries on Par With Other Industries in Country
The legalization of recreational cannabis in Canada has the country preparing for unprecedented expansion and with that will undoubtedly come career opportunities, but what can job seekers expect in regards to Canadian cannabis salaries?
Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?
TMX Group Ltd. (TSX:X), the operator of the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), has reportedly been speaking with regulators to figure out what will happen to Canadian marijuana producers with assets in the U.S.
Why the 3 Hottest Weed Stocks of the Summer Could Get Even Hotter
For many weed stocks, the summer of 2017 hasn’t been what you’d call a scorcher. However, three marijuana stocks have sizzled this summer.
Can Canadian Marijuana Companies Meet the Potentially Huge Demand?
Although the hype has worn off when it comes to Canadian marijuana companies, major growth prospects still exist in this newly emerging industry.
The Average Marijuana Stock Is Up 332% Over the Past Year
Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.
Here’s the Single Most Important Reason More States Will Legalize Marijuana
You don’t have to be Nostradamus to successfully predict that more states will legalize marijuana — whether for medicinal use only or for recreational use.
These 4 Marijuana Stocks All Jumped at Least 10% Last Week
In total, four marijuana stocks jumped higher by at least 10% last week. Let’s take a brief look at some of these moves.
Bad News for Canadian Marijuana Stocks: Say Hello to Your New Competition
Well, we have news for Canadian marijuana stock investors: There’s a new threat on the horizon, at least for our neighbors to the north.
3 Things to Know About Marijuana Stock Canopy Growth Corporation
Only 51 authorized licenses have been given to suppliers of medical marijuana in Canada. Canopy Growth Corporation holds four of them.
Canadian Cannabis Stocks Could Be in Trouble With Health Canada Changes
According to a press release from Health Canada in late May, big changes are coming to the country’s medical cannabis program.
The Very First Cannabis Stock ETF is Now in Bear-Market Territory
The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.
Tetra Bio-Pharma Appoints Aphria CFO, Mr. Carl Merton to the Board of Directors
OTTAWA, Ontario, June 14, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP) (OTCQB:TBPMF), today announced that it has appointed Mr. Carl A. Merton to the Board of Directors effective immediately.
Say Hello to the Largest North American Marijuana Stock IPO
In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.
Canadian Cannabis Investors Bogart Deals in America
There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.
Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?
If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?
661 Million Reasons to Like These 3 Cannabis Stocks
Here’s why these three cannabis stocks are in better shape than most others in the market. Take a deeper look into GW Pharmaceuticals, Insys Therapeutics, and Aphria.
Better Know a Marijuana Stock: Canopy Growth Corp.
A major Canadian medical marijuana player, Canopy Growth is a producer and retailer of medical cannabis products and oils in our neighbor to the north. It’s also the only other marijuana stock other than GW Pharmaceuticals to bear a $1 billion valuation.
The 3 Most Undervalued Marijuana Stocks With a Twist
Marijuana stocks are extremely risky. But, if things go right for these pot stocks over the next two to three years, they could be a steal for investors.
Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation?
With two marijuana stocks already sporting market caps over $1 billion, one of these four pot stocks is likely to be next.
3 Pot Stocks That Will Benefit if Canada Legalizes Recreational Weed
Three Canadian medical cannabis companies, which have been expanding their growth operations like crazy over the past couple of quarters, could be in line for significant sales growth if Trudeau’s legislation passes.
Aphria Launches US Expansion Strategy
LEAMINGTON, Ontario, April 4, 2017 /Weed Wire/ – Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF) is pleased to announce the launch of its US expansion strategy through a strategic lead investment in an entity to be renamed Liberty Health Sciences Inc. (“Liberty”) that will operate in the United States under the brand “Aphria USA”.
Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%
LEAMINGTON, Ontario, March 27, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).
Aphria Continues Success Story With TSX Listing
LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.
Top 5 States for Marijuana Stocks
Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.
This Marijuana Stock Is Already Worth $1 Billion
Canopy Growth Corporation’s generating eye-popping returns for investors. However, there are risks ahead that could rein in some investor optimism.
Will Falling Cannabis Prices Hurt Marijuana Stocks?
Marijuana prices are falling. Could marijuana stock prices drop soon, too?
Aphria Receives Conditional Approval to Graduate to the TSX
LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.
Aphria’s Vision to be Reality – Part IV Expansion Project to Increase Greenhouse Growing Space to 1 Million Square Feet
LEAMINGTON, Ontario, Jan. 16, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion.
Aphria Reports 19% Growth in Quarterly Revenue
LEAMINGTON, Ontario, Jan. 11, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) today reported its second quarter results, for the three months ended November 30, 2016.
Aphria Continues Expansion Strategy
LEAMINGTON, Ontarion, Dec. 14, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.
Canadian Investors Gain Access to US Cannabis Companies
For now, CannaRoyalty is also the only option for Canadian investors to gain exposure to the U.S. recreational marijuana market.
Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials
OTTAWA, Ontario, Dec. 6, 2016 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (OTC PINK:GRPOF) is conducting a non-brokered private placement with Aphria Inc. (OTCQB:APHQF).
Aphria Inc. Announces $35 Million Bought Deal
LEAMINGTON, Ontario, Nov. 11, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc.
Aphria Enters Into IP Transfer Agreement in Arizona
LEAMINGTON, Ontario, Oct. 27, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that it has entered into an Intellectual Property transfer agreement with Copperstate Farms, LLC (“Copperstate”).
MassRoots Completes $5.0 Million Equity Financing
DENVER, Oct. 21, 2016 /Weed Wire/ — MassRoots, Inc. (OTCQB: MSRT), one of the leading technology platforms for the cannabis industry, is pleased to announce it has completed a $5.0 million equity offering under its Registration Statement, declared effective by the Securities and Exchange Commission on August 11, 2016.
Aphria and MassRoots Partner in One of First International Collaborations between Cannabis Companies
LEAMINGTON, Ontario, Oct. 18,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX-V: APH or USOTCQB: APHQF) one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc. (OTCQB:MSRT), one of the largest technology platforms for the cannabis industry, are pleased to announce they have entered into one of the first international partnerships between cannabis companies.
Aphria Announces Licence Amendment
LEAMINGTON, Ontario, Sept. 26, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced an amendment to is licence by Health Canada, allowing it to grow up to 3,600 kilograms of dried cannabis and to sell up to 2,800 kilograms of dried cannabis, over the next year.
Aphria Finalizes Licensing Deal With Tokyo Smoke
TORONTO, Ontario, Sept. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria”) (TSX VENTURE:APH)(OTCQB:APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has issued to Tokyo Smoke 38,759 common shares of Aphria and 200,000 common share purchase warrants exercisable for a period of 5 years at an exercise price of $3.14 per warrant.